All patients | NACG | ACG | p | |
---|---|---|---|---|
N = 60 | N = 28 (%) | N = 32 (%) | ||
Age (median) | 41.0 | 41.5 | 40.5 | 0.410 |
Tumor size (cm) | 8 | 7 | 8.4 | 0.523 |
Serum Ca125(U / ml) | 15.5 | 14.4 | 16.4 | 0.751 |
Menopause | 0.744 | |||
Yes | 14 (23.3) | 6 (21.4) | 8 (25.0) | |
No | 46 (76.7) | 22 (78.6) | 24 (75.0) | |
FIGO stage (%) | 0.944 | |||
IC1 | 34 (56.7) | 16 (57.1) | 18 (56.2) | |
IC2-IC3 | 26 (43.3) | 12 (42.9) | 14 (43.8) | |
Surgical procedure | 0.605 | |||
Fertility surgery | 30 (50.0) | 15 (53.6) | 15 (46.9) | |
Radical surgery | 30 (50.0) | 13 (46.4) | 17 (53.1) | |
Staging operation | 0.102 | |||
Yes | 26 (43.3) | 9 (32.1) | 17 (53.1) | |
No | 34 (56.7) | 19 (67.9) | 15 (46.9) | |
Lymphadenectomy | 0.245 | |||
Yes | 24 (40.0) | 9 (32.1) | 15 (46.9) | |
No | 36 (60.0) | 19 (67.9) | 17 (53.1) | |
First operation at clinical | 0.696 | |||
Our clinical | 37 (61.7) | 18 (64.3) | 19 (59.4) | |
Outer | 23 (38.3) | 10 (35.7) | 13 (40.6) |